BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19477201)

  • 1. Production and characterization of antibodies against vaccinia virus DNA polymerase.
    Magee WC; Shahhosseini S; Lin YC; Suresh MR; Evans DH
    J Virol Methods; 2009 Oct; 161(1):44-51. PubMed ID: 19477201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin-independent plasmid replication occurs in vaccinia virus cytoplasmic factories and requires all five known poxvirus replication factors.
    De Silva FS; Moss B
    Virol J; 2005 Mar; 2():23. PubMed ID: 15784143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Vaccinia Virus Replisome and Transcriptome Proteins by Isolation of Proteins on Nascent DNA Coupled with Mass Spectrometry.
    Senkevich TG; Katsafanas GC; Weisberg A; Olano LR; Moss B
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28747503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibodies recognize early and late viral proteins of human cytomegalovirus.
    Alexander H; Harpprecht J; Podzuweit HG; Rautenberg P; Müller-Ruchholtz W
    Hum Antibodies Hybridomas; 1994; 5(1-2):81-90. PubMed ID: 7858186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a processive form of the vaccinia virus DNA polymerase.
    McDonald WF; Klemperer N; Traktman P
    Virology; 1997 Jul; 234(1):168-75. PubMed ID: 9234958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinia virus DNA polymerase promotes DNA pairing and strand-transfer reactions.
    Willer DO; Mann MJ; Zhang W; Evans DH
    Virology; 1999 May; 257(2):511-23. PubMed ID: 10329561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of polyclonal antibodies against the capsid proteins of Ljungan virus.
    Tolf C; Ekström JO; Gullberg M; Arbrandt G; Niklasson B; Frisk G; Liljeqvist JA; Edman K; Lindberg AM
    J Virol Methods; 2008 Jun; 150(1-2):34-40. PubMed ID: 18403027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Confirmation that the H5 Protein Is Required for Vaccinia Virus DNA Replication.
    Boyle KA; Greseth MD; Traktman P
    J Virol; 2015 Jun; 89(12):6312-27. PubMed ID: 25855734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies against the nucleocapsid proteins of henipaviruses: production, epitope mapping and application in immunohistochemistry.
    Xiao C; Liu Y; Jiang Y; Magoffin DE; Guo H; Xuan H; Wang G; Wang LF; Tu C
    Arch Virol; 2008; 153(2):273-81. PubMed ID: 17978885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of recombinant vaccinia viruses using leporipoxvirus-catalyzed recombination and reactivation of orthopoxvirus DNA.
    Yao XD; Evans DH
    Methods Mol Biol; 2004; 269():51-64. PubMed ID: 15114007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro concatemer formation catalyzed by vaccinia virus DNA polymerase.
    Willer DO; Yao XD; Mann MJ; Evans DH
    Virology; 2000 Dec; 278(2):562-9. PubMed ID: 11118378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron-microscopical observations on the development of vaccinia, cowpox and monkeypox viruses in pig skin.
    Soekawa M; Moriguchi R; Morita C; Kitamura T; Tanaka Y
    Zentralbl Bakteriol Orig A; 1977 Apr; 237(4):425-43. PubMed ID: 194436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of monoclonal antibodies specific for vaccinia virus.
    Meng X; Xiang Y
    Methods Mol Biol; 2012; 890():219-32. PubMed ID: 22688770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of vaccinia virus replication by peptide aptamers.
    Saccucci L; Crance JM; Colas P; Bickle M; Garin D; Iseni F
    Antiviral Res; 2009 Jun; 82(3):134-40. PubMed ID: 19428604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of a large panel of murine monoclonal antibodies against vaccinia virus.
    Meng X; Zhong Y; Embry A; Yan B; Lu S; Zhong G; Xiang Y
    Virology; 2011 Jan; 409(2):271-9. PubMed ID: 21056889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies to cowpox virus: polypeptide analysis of several major antigens.
    Kitamoto N; Tanimoto S; Hiroi K; Ozaki M; Miyamoto H; Wakamiya N; Ikuta K; Ueda S; Kato S
    J Gen Virol; 1987 Jan; 68 ( Pt 1)():239-46. PubMed ID: 3806058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methods for analysis of poxvirus DNA replication.
    Traktman P; Boyle K
    Methods Mol Biol; 2004; 269():169-86. PubMed ID: 15114016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of the calcium antagonist, verapamil, on measles and vaccinia replication in cell culture.
    Shainkin-Kestenbaum R; Winikoff Y; Chaimovitz C; Zimlichman S; Sarov I
    Isr J Med Sci; 1993 Jan; 29(1):2-6. PubMed ID: 8454440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification and characterization of a monoclonal antibody to the vaccinia virus E3 protein.
    Weaver JR; Shamim M; Alexander E; Davies DH; Felgner PL; Isaacs SN
    Virus Res; 2007 Dec; 130(1-2):269-74. PubMed ID: 17583368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infection with vaccinia favors the selection of hybridomas synthesizing autoantibodies against intermediate filaments, one of them cross-reacting with the virus hemagglutinin.
    Dales S; Fujinami RS; Oldstone MB
    J Immunol; 1983 Sep; 131(3):1546-53. PubMed ID: 6684139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.